WHO Workshop on Lassa Vaccine evaluation 24 April INSERM, 101 rue de Tolbiac, Paris LIST OF PARTICIPANTS

Similar documents
Childhood Vaccination and Immunisation

Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report of the Advisory Group

Research Priorities to Inform Public Health and Medical Practice for Domestic Zika Virus: A Workshop

The Future of Health in Africa

Appendix A: PROBABILITY OF INSECT TRANSMISSION

GloPID-R. Objectives, governance, activities, priorities. Joint meeting. DG Research & Innovation - Acting Director Health

How to launch a parallel or sequential pathways for experimental evaluation of Ebola candidate vaccines in Phase 3 Ebola vaccine clinical trials?

Working Group on H5N1 Influenza Vaccines

REPORT ON THE RESEARCH UNIT: Virology Department

JAY A. NELSON, PH.D. Executive Director and Vice President

Early Intervention and Diagnosis in Paediatric Neurodevelopment Defects in Brazil, November, Rio de Janeiro, Brazil

Prevention and Healthy Life

Report of the Third Meeting of the Pandemic Influenza Preparedness (PIP) Framework 2016 Review Group

Non-Invasive Neuromodulation of the Central Nervous System: A Workshop. March 2 and 3, 2015

Public Health Wales Phase 1 Implementation Programme Report Appendix 2 APPENDIX 2 EXPERT ADVISORY GROUPS MEMBERSHIP

Health in Post-Conflict and Fragile States: Challenges for the Next Decade

SUMMARY OF THE DISCUSSION AND RECOMMENDATIONS OF THE SARS LABORATORY WORKSHOP, 22 OCTOBER 2003

Adverse Reactions to HIV Vaccines: Medical, Ethical, and Legal Issues. September OTA-BP-H-163 GPO stock #

PAEDIATRIC ASSOCIATION OF NIGERIA & CONTRIBUTIONS TO IMMUNIZATIONS IN NIGERIA

Committee to Advise on Tropical Medicine and Travel (CATMAT)

Pasteur course MODELING OF INFECTIOUS DISEASES

HHS Federal Partners Integrated Care Meeting. State of the Art: Research, Models, Promising Practices and Sustaining Integrated Care

Estimating the contribution of human-to-human. transmission to Lassa fever

Programme Malaria integration of new tools for zero deaths and elimination Monday 20 Wednesday 22 February 2012 WP1141

REPORT OF THE MEETING OF THE OIE AD HOC GROUP ON RIFT VALLEY FEVER Paris, 9 11 October 2012

Readiness for Microbial Threats 2030: Exploring Lessons Learned since the 1918 Influenza Pandemic A Workshop

Branch: Greece Director: Aris Antsaklis Established: Year 2004

Welcome to. The Fundamentals of International Clinical Research Workshop. Stevenson, Washington

Diversity Clinical Research Workshop Invited Faculty

Curriculum Vitae. W. Andrew Achenbaum, Ph.D.

Masterclass on Clinical Research: How to design a clinical trial

CLINICAL PATHWAY TRACK AGENDA TUESDAY, AUGUST 23, 2016

Mr. Bruce Allen. Dr. Harvey Clewell.

Published over 200 peer-reviewed papers, mainly in refereed international scientific journals.

Israel Makov President and Chief Executive Officer Teva

H1N1 Vaccination Campaigns: Integrated Communication, Distribution, and Administration Strategies. A Regional Workshop Series.

RCSI HMC POSTGRADUATE DENTAL EDUCATION PAEDIATRIC SPECIALTY PROGRAMME. April 7th/June 16th

Francine Ntoumi PhD, HDR, FRCP Coordinator Fondation Congolaise pour la Recherche Medicale, Brazzaville, Congo

Youth Work and Smoking Prevention. Alastair MacKinnon Chief Executive FAST FORWARD

Let s outsmart epidemics

BEAUTIFUL Executive Committee

Influenza Specialist Group 2015 Program Annual Scientific Meeting 1 & 2 February 2015 Park Royal Hotel Melbourne Airport Melbourne, Australia

The World Health Organization: Does it have a Role in Critical Illness?

Associate Professor, HIV Focal Person, KBTH

Getting It Right: Securing Sexual and Reproductive Health and Rights and Family Planning in the Post-2015 Agenda Parallel Session 4E July 1, 2014

Collaboration with Traditional Healers in the Provision of Skin Care for All in Africa

Innovation, Access and Delivery for Universal Health Coverage

Scientific and Medical Differences of Category A Pathogens

UNRAVELING THE MYSTERY BEHIND HIV/AIDS

PROGRAMME. DAY 1 (Tuesday, 21 November 2017) Katowice - Poland. 12:45 13:15 How to write the Methods section lecture John Carpenter (UK)

2015 Global Health Forum in Taiwan

TITHE: EFFECT OF HAEMOGLOBINOPATHY IN OUR SOCIETY

JOINT WHO & UNAIDS ANNUAL CONSULTATION WITH PHARMACEUTICAL COMPANIES ON GLOBAL FORECASTS OF ANTIRETROVIRAL DEMAND

CURRICULUM VITAE - Professor Fred Torgbor Sai

October 15 & WORKSHOP ON DRUG DISCOVERY AND INFECTIOUS DISEASE. IMéRA, Maison des astronomes, Marseille

Hassenfeld Conference Center, Brandeis University 415 South Street, Waltham, MA BIOGRAPHICAL SKETCHES OF CONFERENCE PRESENTERS

2018 Current Fiscal Year Report: Board of Scientific Counselors Office of Infectious Diseases

OVERVIEW OF COMMUNICABLE DISEASE SURVEILLANCE SYSTEM IN BULGARIA

Section V. NEUROFIBROMATOSIS RESEARCH PROGRAM

PROVINCIAL LEAD AND LHIN LEADER BIOS

LASSA VIRUS HAEMORRAGIC FEVER IN BENIN Diagnostic- biosecurity-perspectives

Epidemiological situation on rotavirus infection and prospects for vaccination introduction in the Republic of Belarus

Second China-U.S. Workshop on the Challenges of Emerging Infections, Laboratory Safety and Global Health Security

WHO working Group Committee meeting on Evidence Based Traditional Medicine

Itinerary for the Field School. Social Science Research Techniques for Post Conflict Areas October 2015

After 1918: History and Politics of Influenza in the 20 th and 21 st Centuries

Overview of the ProVac Initiative

INSTITUTO DE SALUD CARLOS III (ISCIII)

The WHO-EC Partnership Project on User Empowerment in Mental Health

Day1- Monday 7 May 2018 OPENING REMARKS AND COURSE INTRODUCTION EPIDEMIOLOGY AND ECOLOGY VIROLOGY

PHS 801 EPIDEMIOLOGY OF INFECTIOUS DISEASES (3 credits)

Task Force Members: Mandy Lauw, Chairman Geoff Barnes, Immediate Past Chairman

Public Health Programme : Information Day Work shop: Health Threats

Where is the frontline in the battle against infectious diseases?

Speakers Biographical Profiles

Report of a WHO technical working group meeting on dengue prevention and control

COMMUNICABLE DISEASES SURVEILLANCE SYSTEM IN BULGARIA

AIDS Testing Methodology and Management Issues

To the memory of FRANCIS E. CAMPS

Gold Medal. nd Annual Albert B. Sabin. Award Ceremony. Roger I. Glass, M.D., Ph.D. Presented to

ADDRESSING INEQUITIES IN CANCER PREVENTION CALLING FOR HPV VACCINATION FOR BOYS AND GIRLS

1-2 December 2015 Geneva, Switzerland. Anticipating emerging infectious disease epidemics

th Annual Albert B. Sabin Gold Medal Award Ceremony

Alzheimer Europe Conference Berlin, 2-4 October Special Symposium 4 October, , Room II. Eli Lilly and Company

Genetic Counseling and Cystic Fibrosis Carrier Screening: Results of a Survey. October OTA-BP-BA-97 NTIS order #PB

Annual Academic Meeting (Incorporating the Annual Blair Bell Research Society Competition) Joint RCOG/Blair Bell Research Society

2015/LSIF/FOR/001. Program. Submitted by: United States

Advanced Lecture on One Health

GLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW

BSGE Council Member Declaration of Interests 2017

The Neurocognitive and Psychosocial Impacts of Violence and Trauma: A Workshop July 31 August 1, 2017

Alliance Organizational Structure. Trini Ajazi, MM Alliance Chief Administrative Officer Clinical Research Professional Orientation

Thursday 1 December (The University Club of Western Australia Theatre Auditorium unless otherwise indicated)

The PsySSA/APA MOU partnership picks up momentum

Air Pollution & mhealth Prevention and Control of Chronic Respiratory Diseases

LET S TALK ABOUT INFECTION CONTROL AND OSHA

CLARIFY Executive Committee

Public Safety and Health Cooperation from the Canadian Perspective

PARALLEL SESSION 1.1

Transcription:

WHO Workshop on Lassa Vaccine evaluation 24 April 2018 - INSERM, 101 rue de Tolbiac, 75013 Paris LIST OF PARTICIPANTS Participants Prof George O. Akpede Department of Paediatrics, College of Medicine, Ambrose Alli University Dr Danny Asogun Associate Professor, Department of Community Medicine, Ambrose Alli University / Irrua Specialist Teaching Hospital, Dr Augustin Augier Secretary General, ALIMA - The Alliance for International Medical Action, Prof Daniel G. Bausch Director, Public Health Rapid Support Team, Dr Sina Bavari Chief Scientific Officer/Scientific Director US. Army Medical Research Institute of Infectious Diseases, Prof Victor De Gruttola (TC) Professor of Biostatistics, Department of Biostatistics, Harvard School of Public Health, Prof W. John Edmunds Professor, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine,

Prof Susan S. Ellenberg Professor of Biostatistics Department of Biostatistics and Epidemiology University of Pennsylvania Perelman School of Medicine, Prof Thomas R. Fleming Professor of Biostatistics, School of Public Health, University of Washington, Dr Christiane Gerke Head of Vaccine Programs, Development Department, Institut Pasteur, Dr Donald Grant (TC) Chief Physician of the Viral Hemorrhagic Fever ward, Kenema Government Hospital, Ministry of Health and Sanitation of Sierra Leone, Sierra Leone Prof Stephan Guenther Head, Department of Virology, Bernhardt-Nocht-Institute for Tropical Medicine, Germany Dr Norheim Gunnstein Director, Vaccine Science, CEPI Dr Chikwe Ihekweazu Chief Executive Officer, Centre for Disease Control, Prof Albert I. Ko Professor of Epidemiology and Medicine, Chair Department of Epidemiology of Microbial Diseases, Yale School of Public Health,

Dr Philip R. Krause Deputy Director, Center for Biologics Evaluation and Research, US Food and Drug Administration, Dr Gianni Lo Iacono Lecturer in Biostatistics/Epidemiology, University of Surrey, Prof Yves Lévy Chief Executive Officer INSERM Prof Ira M. Longini Professor of Biostatistics, Department of Biostatistics, University of Florida, Prof Denis Malvy Head of the Tropical Medicine Unit, University Hospital of Bordeaux and INSERM, Dr Martha C. Nason Mathematical Statistician, Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Dr Edwin Nkansah Head of Biological Products Units, Ghana Food and Drug Administration, Ghana Prof Sylvanus Okogbenin Chief Medical Director, Irrua Specialist Teaching Hospital, Dr Robinson Chukwudi Onoh Chairman, Medical Advisory Committee on Viral Hemorrhagic Fever, Federal Teaching Hospital Abakaliki,

Dr Pierre E. Rollin Deputy Branch Chief, Viral Special Pathogens Branch, National Center for Emerging and Zoonotic Diseases, Center for Disease Control and Prevention, Dr David Safronetz Chief of Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Canada Dr Connie Schmaljohn Senior Research Scientist, US Army Medical Research Institute of Infectious Diseases, Prof Yazdan Yazdanpanah Director, Immunology, Inflammation and Microbiology, INSERM,

WHO Secretariat Dr Alejandro Costa Initiative for Vaccine Research Dr Janet Diaz Team Lead - Clinical Management, World Health Emergencies programme, World Health Organization, Switzerland Dr Pierre B. Formenty Team Lead - Viral Haemorrhagic Fevers, World Health Emergencies programme, World Health Organization, Switzerland Dr Pierre-Stephane Gsell Initiative for Vaccine Research Dr Ana Maria Henao Restrepo Team Lead - Initiative for Vaccine Research & R&D Blueprint Coordinator Dr Konstantin Volkmann Consultant - Initiative for Vaccine Research Dr Karene Yeung Consultant - Initiative for Vaccine Research

Observers Dr Eric D'Ortenzio Scientific Coordinator, REACTing, INSERM, Dr P. Guillaume Poliquin Senior Medical Advisor, Paediatric Infections Diseases Specialist, National Microbiology Laboratory, Canada Prof Michael Ramharter Head of Division of Tropical Medicine, Germany Dr Alex Salam Clinical, Public Health Rapid Support Team, Dr Melanie Saville Director, Vaccine Development, CEPI Dr Conall Watson Department of Infectious Disease Epidemiology London School of Hygiene and Tropical Medicine,